Gilead's virology drug head to take East Coast biotech's CEO post

Diana Brainard's new cell therapy company is working on off-the-shelf virus-specific T cell drug therapy candidates targeting 12 viruses, including the coronavirus that causes Covid-19.
Source: bizjournals.com Health Care News Headlines - Category: Health Management Authors: Source Type: news